Low Concentration Atropine for Myopia Progression in School Children

Status Completed

Clinical Trial Summary

Myopia is the leading cause of blindness in Taiwan. The younger children with myopia, the higher risk of high myopia in later life and complications such as retinal detachment and maculopathy will occur. We have reported the low concentration of atropine (0.05%) with the effect on retarding the myopia progression. Recently the 0.01% atropine was also reported effective and with less visual side effects such as mydriasis. The aim of this study is to compare the efficacy in controlling myopia progression and visual side effects of 2 low concentration of atropine(0.05% vs 0.01%) in children aged 6-12 years with myopia of at least -0.5 diopters (D) and astigmatism of -1.50 D or less.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02130167
Study type	Interventional
Source	Chang Gung Memorial Hospital
Contact
Status	Completed
Phase	N/A
Start date	August 2012
Completion date	August 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06034327` - Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens	N/A
Not yet recruiting	`NCT06265454` - Low Dose Atropine Eye Drops in Myopic Egyptian Children	Phase 2
Recruiting	`NCT02623543` - Effectiveness of Orthokeratology in Decreasing Myopic Progression in a Young Adult Population Enrolled in a Professional Optometric Curriculum	Phase 2
Completed	`NCT05700240` - Effect of Orthokeratology on Myopia Progression in French Children
Active, not recruiting	`NCT05893979` - Myopia Control Spectacle Lens Cessation Study	N/A
Active, not recruiting	`NCT05617794` - Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness	N/A
Active, not recruiting	`NCT03952702` - Overminus Lens Therapy in Intermittent
Completed	`NCT05650190` - Spectacle Lens Visual Acuity Assessments Study	N/A
Not yet recruiting	`NCT03381079` - Efficacy and Safety of Posterior Scleral Reinforcement on Controlling Myopia in Adults With High Myopia	Phase 2